In 2003, I wrote a 367-word biography of Alexander Hamilton for Columbia University as part of the Columbia 250 celebration. I remember struggling with it and the 30 or so other biographies we had committed to write for the launch of...
It’s been awfully quiet on the Orangefiery blog. Too quiet. Fifteen months since our last post? That’s outrageous! All we can offer is a typical excuse: We’ve been really busy. It’s true. Business is good and growing. We’ve got a dozen clients...
It was, according to Turing Pharmaceuticals CEO Martin Shkreli, “a great business decision that also benefits all of our stakeholders.” Not so fast, buddy. Shkreli was referring to his company’s decision to raise the price of Daraprim, a treatment for toxoplasmosis it...
Imagine, if you will, a hypothetical scenario for the 2016 presidential election. After a tough series of primary battles, former Washington Gov. Christine Gregoire[i], is drafted out of retirement by enthusiastic Democratic supporters into the South Carolina primary and secures...
It was January 2004, and I was meeting with my boss when a colleague knocked on the door and popped in. “Hey, did you see ‘The Apprentice’ last night?” My boss and I looked at each other and smirked. “No.” The smirk...
Today marks the 111th anniversary of the day on which James Joyce first went strolling around Dublin with his future wife, Nora Barnacle. Also, the date on which Joyce imagined a short story taking place that would follow an ad...
“… just because the data don’t exist to demonstrate the effectiveness of this method of changing minds, doesn’t mean the hypothesis is false.” This sounds like a weird riff on a famous line from Joseph Heller’s Catch-22. But, this isn’t a...
In Week 7 of what was a tough 2014 NFL season, Patriots Quarterback Tom Brady was ticked off. It was halftime, October 16. Patriots v. Jets. At home. New England was up 17-12, in a surprisingly feisty matchup. At the time,...
Years ago, I was part of a team that was hired to help a pharmaceutical company explain to America why its industry was a good thing. This was not an easy task, obviously. The pharmaceutical industry has a weak reputation overall,...
Last month, Silicon Valley was abuzz with the unfolding saga of Ellen Pao’s gender bias case against venture capital firm Kleiner, Perkins, Caufield & Byers. A former junior partner at KPCB, Pao, 45, alleged that male partners there engaged in a...